Afya Limited (NASDAQ:AFYA – Get Free Report)’s stock price reached a new 52-week low on Thursday. The company traded as low as $9.95 and last traded at $10.15, with a volume of 135,001 shares. The stock had previously closed at $10.24.
Wall Street Analyst Weigh In
A number of analysts have recently issued reports on the company. Bradesco Corretora raised Afya to an “outperform” rating and set a $17.00 price target on the stock in a research note on Thursday, September 24th. JPMorgan Chase & Co. raised shares of Afya from a “neutral” rating to an “overweight” rating and dropped their price objective for the company from $21.00 to $19.00 in a report on Wednesday, October 7th. Wall Street Zen cut shares of Afya from a “buy” rating to a “hold” rating in a research note on Saturday. Weiss Ratings cut Afya from a “hold (c-)” rating to a “sell (d+)” rating in a report on Thursday. Finally, Bank of America raised Afya from a “neutral” rating to a “buy” rating and set a $16.00 target price for the company in a research note on Thursday. Three investment analysts have rated the stock with a Buy rating, three have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $17.00.
Read Our Latest Stock Analysis on AFYA
Afya Price Performance
The company’s 50 day moving average price is $13.63 and its 200 day moving average price is $14.20. The company has a market cap of $979.41 million, a price-to-earnings ratio of 6.37, a PEG ratio of 1.23 and a beta of 0.34. The company has a current ratio of 2.20, a quick ratio of 2.20 and a debt-to-equity ratio of 0.39.
Afya (NASDAQ:AFYA – Get Free Report) last issued its quarterly earnings results on Friday, August 14th. The company reported $0.43 EPS for the quarter, beating analysts’ consensus estimates of $0.40 by $0.03. Afya had a return on equity of 17.58% and a net margin of 20.55%. The firm had revenue of $187.80 million during the quarter, compared to the consensus estimate of $189.62 million. Equities research analysts forecast that Afya Limited will post 1.72 earnings per share for the current year.
Insider Activity
In other news, insider Santos Welder Ferreira sold 4,161 shares of Afya stock in a transaction that occurred on Monday, October 5th. The shares were sold at an average price of $13.30, for a total value of $55,341.30. Following the transaction, the insider owned 35,000 shares of the company’s stock, valued at $465,500. This trade represents a 10.63% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 0.80% of the stock is currently owned by corporate insiders.
Hedge Funds Weigh In On Afya
An institutional investor recently bought a new stake in Afya stock. Engineers Gate Manager LP purchased a new stake in Afya Limited (NASDAQ:AFYA – Free Report) during the second quarter, according to its most recent filing with the SEC. The firm purchased 21,882 shares of the company’s stock, valued at approximately $325,000. 88.02% of the stock is currently owned by hedge funds and other institutional investors.
Afya Company Profile
Afya Limited is a medical education and digital health company focused on Brazil. Through its educational platform, the company provides undergraduate medical education, medical residency preparation, specialization and continuing medical education programs, and other learning resources for students and physicians.
Afya also offers digital products and services intended to support healthcare professionals throughout their careers. These include clinical content, study tools, telemedicine and practice-management solutions, and subscription-based applications designed to assist physicians with education, clinical decision-making, and patient care.
The company has expanded through the development and acquisition of medical schools, education businesses, and health technology platforms serving different stages of the medical professional lifecycle.
See Also
- Five stocks we like better than Afya
- Can Microsoft Turn a Leaner Workforce and Record AI Spending Into Bigger Profits?
- Why JFrog Could Be the Software Infrastructure Company to Beat in the AI Boom
- The Factories Behind AI Servers Just Raised Their Outlooks—3 Contract Manufacturers to Watch
- MarketBeat Week in Review – 10/26 – 10/30
Receive News & Ratings for Afya Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Afya and related companies with MarketBeat.com's FREE daily email newsletter.
